SEARCH

SEARCH BY CITATION

References

  • 1
    Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 815.
  • 2
    Steinberg DM, Cooke WT, Alexander-Williams J. Abscess and fistulas in Crohn's disease. Gut 1973; 14: 8659.
  • 3
    Farmer RG, Hawk WA, Turnbull RB Jr. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology 1975; 68: 62735.
  • 4
    Rankin GB, Watts HD, Melnyk CS, et al. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979; 77: 91420.
  • 5
    Williams DR, Coller JA, Corman ML, et al. Anal complications in Crohn's disease. Dis Colon Rectum 1981; 24: 224.
  • 6
    Hellers G, Bergstrand O, Ewerth S, et al. Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. Gut 1980; 21: 5257.
  • 7
    Schwartz DA, Loftus EV Jr, Tremaine WJ, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122: 87580.
  • 8
    Present DH. Crohn's fistula: current concepts in management. Gastroenterology 2003; 124: 162935.
  • 9
    Bernstein LH, Frank MS, Brandt LJ, et al. Healing of perineal Crohn's disease with metronidazole. Gastroenterology 1980; 79: 35765.
  • 10
    Brandt LJ, Bernstein LH, Boley SJ, et al. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 1982; 83: 3837.
  • 11
    Jakobovits J, Schuster MM. Metronidazole therapy for Crohn's disease and associated fistulas. Am J Gastroenterol 1984; 79: 53340.
  • 12
    Turunen U, Farkkila M, Valtonen V. Long-term outcome of ciprofloxacin treatment in severe perianal or fistulous Crohn's disease. Gastroenterology 1993; 104: A793(Abstract).
  • 13
    Solomon MJ, McLeod RS, Connor BI, et al. Combination ciprofloxacin and metronidazole in severe perianal Crohn's disease. Can J Gastroenterol 1993; 7: 5713.
  • 14
    Present DH, Korelitz BI, Wisch N, et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980; 302: 9817.
  • 15
    Korelitz BI, Present DH. Favorable effect of 6-mercaptopurine on fistulas of Crohn's disease. Dig Dis Sci 1985; 30: 5864.
  • 16
    Hanauer SB, Smith MB. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporine A. Am J Gastroenterol 1993; 88: 6469.
  • 17
    Present DH, Lichtiger S. Efficacy of cyclosporine in treatment of fistula of Crohn's disease. Dig Dis Sci 1994; 39: 37480.
  • 18
    Sandborn WJ. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease. Am J Gastroenterol 1997; 92: 8769.
  • 19
    Sandborn WJ, Present DH, Isaacs KL, et al. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 2003; 125: 3808.
  • 20
    Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340: 1398405.
  • 21
    Schwartz DA, Pemberton JH, Sandborn WJ. Diagnosis and treatment of perianal fistulas in Crohn's disease. Ann Intern Med 2001; 135: 90618.
  • 22
    Hanauer SB, Sandborn W, and The Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol 2001; 96: 62543.
    Direct Link:
  • 23
    Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 24: 26.
  • 24
    Irvine EJ. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 1995; 20: 2732.
  • 25
    Parks AG, Gordon PH, Hardcastle JD. A classification of fistula-in-ano. Br J Surg 1976; 63: 112.
  • 26
    Lichtenstein GR. Treatment of fistulizing Crohn's disease. Gastroenterology 2000; 119: 113247.
  • 27
    Makowiec F, Jehle EC, Starlinger M. Clinical course of perianal fistulas in Crohn's disease. Gut 1995; 37: 696701.
  • 28
    Arnold GL, Beaves MR, Pryjdun VO, et al. Preliminary study of ciprofloxacin in active Crohn's disease. Inflamm Bowel Dis 2002; 8: 105.
  • 29
    Pearson DC, May GR, Fick GH, et al. AZA and 6-mercaptopurine in Crohn's disease. A meta-analysis. Ann Intern Med 1995; 123: 13242.
  • 30
    Garrett JW, Drossman DA. Health status in IBD: biological and behavioural considerations. Gastroenterology 1990; 99: 906.
  • 31
    Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002; 122: 51230.
  • 32
    Arseneau KO, Cohn SM, Cominelli F, et al. Cost-utility of initial management for Crohn's disease perianal fistulas. Gastroenterology 2001; 120: 164056.